Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant

A. K. Chapman; Susan W Aucott; A. M. Milstone

doi:10.1038/jp.2011.148

Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant

A. K. Chapman, Susan W Aucott, A. M. Milstone

School of Medicine

Research output: Contribution to journal › Article › peer-review

61 Scopus citations

Abstract

Chlorhexidine gluconate (CHG) is a widely used topical antiseptic that is recommended by the Centers for Disease Control and Prevention for skin cleansing before central venous catheter insertion in adults and children. Because of limited safety data, CHG is not recommended for use in children <2 months of age. CHG is, however, frequently used in Neonatal Intensive Care Units across the United States. Here, we will review the safety of CHG use in preterm infants.

Original language	English (US)
Pages (from-to)	4-9
Number of pages	6
Journal	Journal of Perinatology
Volume	32
Issue number	1
DOIs	https://doi.org/10.1038/jp.2011.148
State	Published - Jan 2012

Keywords

chlorhexidine gluconate
drug safety
drug toxicity
neonates
prematurity

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Obstetrics and Gynecology

Access to Document

10.1038/jp.2011.148

Cite this

@article{00e225edcfed4efd8fe024b36516e36c,

title = "Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant",

abstract = "Chlorhexidine gluconate (CHG) is a widely used topical antiseptic that is recommended by the Centers for Disease Control and Prevention for skin cleansing before central venous catheter insertion in adults and children. Because of limited safety data, CHG is not recommended for use in children <2 months of age. CHG is, however, frequently used in Neonatal Intensive Care Units across the United States. Here, we will review the safety of CHG use in preterm infants.",

keywords = "chlorhexidine gluconate, drug safety, drug toxicity, neonates, prematurity",

author = "Chapman, {A. K.} and Aucott, {Susan W} and Milstone, {A. M.}",

note = "Funding Information: AM receives grant support from the Sage Products. The rest of the authors (AC, SA) report no conflict of interest. Funding Information: We thank Dr Pranita Tamma for her contributions to the manuscript. This manuscript was supported by Grant number UL1 RR 025005 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and the NIH Roadmap for Medical Research, and its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH.",

year = "2012",

month = jan,

doi = "10.1038/jp.2011.148",

language = "English (US)",

volume = "32",

pages = "4--9",

journal = "Journal of Perinatology",

issn = "0743-8346",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant

AU - Chapman, A. K.

AU - Aucott, Susan W

AU - Milstone, A. M.

N1 - Funding Information: AM receives grant support from the Sage Products. The rest of the authors (AC, SA) report no conflict of interest. Funding Information: We thank Dr Pranita Tamma for her contributions to the manuscript. This manuscript was supported by Grant number UL1 RR 025005 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and the NIH Roadmap for Medical Research, and its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH.

PY - 2012/1

Y1 - 2012/1

N2 - Chlorhexidine gluconate (CHG) is a widely used topical antiseptic that is recommended by the Centers for Disease Control and Prevention for skin cleansing before central venous catheter insertion in adults and children. Because of limited safety data, CHG is not recommended for use in children <2 months of age. CHG is, however, frequently used in Neonatal Intensive Care Units across the United States. Here, we will review the safety of CHG use in preterm infants.

AB - Chlorhexidine gluconate (CHG) is a widely used topical antiseptic that is recommended by the Centers for Disease Control and Prevention for skin cleansing before central venous catheter insertion in adults and children. Because of limited safety data, CHG is not recommended for use in children <2 months of age. CHG is, however, frequently used in Neonatal Intensive Care Units across the United States. Here, we will review the safety of CHG use in preterm infants.

KW - chlorhexidine gluconate

KW - drug safety

KW - drug toxicity

KW - neonates

KW - prematurity

UR - http://www.scopus.com/inward/record.url?scp=84855273524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855273524&partnerID=8YFLogxK

U2 - 10.1038/jp.2011.148

DO - 10.1038/jp.2011.148

M3 - Article

C2 - 22031047

AN - SCOPUS:84855273524

SN - 0743-8346

VL - 32

SP - 4

EP - 9

JO - Journal of Perinatology

JF - Journal of Perinatology

IS - 1

ER -

Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this